MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
1.440
-0.150
-9.43%
After Hours: 1.510 +0.07 +4.86% 19:44 03/31 EDT
OPEN
1.570
PREV CLOSE
1.590
HIGH
1.570
LOW
1.420
VOLUME
53.44K
TURNOVER
--
52 WEEK HIGH
23.80
52 WEEK LOW
1.380
MARKET CAP
2.39M
P/E (TTM)
-0.0596
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLMD last week (0324-0328)?
Weekly Report · 17h ago
Weekly Report: what happened at GLMD last week (0317-0321)?
Weekly Report · 03/24 10:27
Galmed Pharmaceuticals Secures New Patent for NASH Therapy
TipRanks · 03/20 21:52
Galmed Pharmaceuticals Announces The Grant Of A New Patent Related To Aramchol; Patent Covers The Use Of A Combination Therapy Of Aramchol And Resmetirom For The Treatment Of Non-Alcoholic Steatohepatitis, Also Known As Metabolic Dysfunction-Associated Steatohepatitis, And Liver Fibrosis
Benzinga · 03/20 12:57
Weekly Report: what happened at GLMD last week (0310-0314)?
Weekly Report · 03/17 10:34
Weekly Report: what happened at GLMD last week (0303-0307)?
Weekly Report · 03/10 10:35
Galmed Research And Development Granted U.S. Patent #12239712 Combination therapy for the treatment of liver disease
Benzinga · 03/04 19:34
Weekly Report: what happened at GLMD last week (0224-0228)?
Weekly Report · 03/03 10:35
More
About GLMD
More
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.
Recently
Symbol
Price
%Change

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.